1)Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 2001; 24:131-53.
2)Faich GA,Fishbein HA,Ellis SE:The epidemiology of diabetic acidosis:a population-based study .Am J Epidemiol 117:551-558,1983.
3)Johnson DD, Palumbo PJ, Chu CP. Diabetic ketoacidosis in a community-based population. Mayo Clin Proc 1980; 55:83-8.
4)Centers for Disease Control and Prevention. Diabetes Surveillance System. Atlanta GA: U.S. Department of Health and Human Services. 2003: Accessed at www.cdc.gov/diabetes/statistics/index.htm on June 10, 2006.
5)Kitabchi AE, Fisher JN, Murphy MB, et al Diabetic ketoacidosis and the hyperglycemic hyperosmolar nonketotic state. In: Joslin's Diabetes Mellitus. 13th ed. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger. 1994; pp. 738-70.
6)Alberti KGMM. Diabetic acidosis, hyperosmolar coma, and lactic acidosis. In Becker KL editor. Principles and Practice of Endocrinology and Metabolism. 3rd ed. Philadelphia. Lippincott Williams & Wilkins. 2001:1438-50.
7)Matz R. Management of hyperosmolar hyperglycemic syndrome. Am Fam Physician 1999; 60:1468-76.
8)Javor KA, Kotsanos JG, McDonald RC, et al. Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care ;1997,20:349-354.
9)National Diabetes data Group :Diabetes in America ed 2.Bethesda ,MD,National Institutes of Health,NIH publication ,1995, No.95-1468.
10)Watchel TJ,Tetu-Mouradjain LM,Goldman DL,Ellis SE,O¿Sallivian PS:Hyperosmolarity and acidosis in diabetes mellitus :a three year experience in Rhode Island.J Gen Int Med,1991;6:495-502.
11)Kitabchi AE,Nyenwe EA.Hyperglycemic Crises in Diabetes Mellitus :Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.Endocrinol Metab Clin N Am,2006,35:725-751.
12)Kitabchi AE,Umpierrez GE,Murphy MB,Kreisberg RA.Hyperglycemic Crises in Adult Patients With Diabetes .A consensus statement from the American Diabetes Association.Diabetes Care;2006,29:2739-2748.
13)Kitabchi AE,Wall BM.Diabetic Ketoacidosis.Med Clin North Am;1995,79:9-37.
14)Ennis ED,Stahl EJVB,Kreisberg RA:The Hyperosmolar hyperglycaemic syndrome.Diabetes Rev,1994;2:115-126.
15)Kitabchi AE, Murphy MB. Hyperglycemic crises in adult patients with diabetes mellitus. In: Oxford Textbook of Endocrinology. Wass JA, Shalet SM, Amiel SA. Oxford University Press. UK. 2002:1734-1747.
16)Kitabchi AE, Fisher JN. Insulin therapy of diabetic ketoacidosis: Physiologic versus Pharmacologic doses of insulin and their routes of administration. In (Brownlee M, ed), Handbook of Diabetes Mellitus, 5:95-149, New York, Garland ATPM Press, 1981.
17)Kitabchi AE,Haerian H,Rose BD.Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycaemic state in adults.UpToDate 2007.
18) Kitabchi AE, Ayyagari V, Guerra SMO. Medical House Staff. The efficacy of low dose versus conventional therapy of Insulin for treatment of diabetic ketoacidosis. Ann Int Med 1976; 84:633-8.
19)Kipnis DM.Insulin secretion in diabetes mellitus.Ann Intern med ;1968,69:891-901.
20)Chupin M,Charbonnel B,Chupin F.C-peptide blood levels in keto-acidosis and in hyperosmolar non-ketotic diabetic coma.Acta Diabet Lat;1981,18:123-128.
21)Muller WA,Faloona GR,Unger RH.Hyperglucagonemia in diabetic ketoacidosis :its prevalence and significance.Am J Med ;1973,54:52-7.
22)Kitabchi AE,Young R,Sacks H,Morris L.Diabetic Ketoacidosis: Reappraisal of Therapeutic Approach.Ann.Rev.Med,1979,30:339-57.
23)Christensen NJ.Plasma norepinephrine and epinephrine in untreated diabetics during fasting and after insulin administration.Diabetes,1974,23:1-8.
24)Jahnke K,Buro F.Das Coma Diabeticum.Verh Dtsch Ges Inn Med ,1970,76:359-70.
25)Unger R.High growth hormone levels in diabetic ketoacidosis :a possible cause of insulin resistance.JAMA ,1965:945-7.
26)Alberti KGM,Hockaday TD.Diabetic coma :serum growth hormone before and during treatment .Diabetologia,1973;9:13-19.
27)Kitabchi AE,Rumbak MJ. Diabetic Ketoacidosis: diagnosis diabetic ketoacidosis :treatment,hyperglycaemic hyperosmolar nonketotic coma;and maintenance treatment after hyperglycaemic crisis In:Callahan ML,Barton CW,Schmaker HM,eds.Decision making in emergency medicine.Philadelphia :BC Decker,1990:178-85.
28)Waldhausl W,Kleinberger G,Korn A ,et al.Severe hyperglycemia :effects of rehydration on endocrine derangements and blood glucose concentration.Diabetes,1979,8:577-84.
29)Foster DW,McGarry JD:Glucose,lipid and protein metabolism.In Griffin JE,Ojeda SR (eds):Textbook of Endocrine Physiology ,ed 3.Newyork,Oxford University Press ,1996,p.349-374.
30)Foster DW,Mc Garry JD :The metabolic derangements and treatment of diabetic ketoacidosis.N Engl J Med,1983,309:159-169.
31)Miles JM,Rizza RA,Haymound MW,Gerich JE.Effects of acute insulin deficiency on glucose and ketone bodies turnover in man :evidence for primary of overproduction of glucose and ketone bodies in the genesis of diabetic ketoacidosis.Diabetes,1980,29:926-30.
32)Fleig P,Wahren J:Influence of endogenous insulin secretion on splanchnic glucose and aminoacid metabolism in man.J Clin Invest ;1971,50:1702-1711.
33)Hue L:Gluconeogenesis and its regulation.Diabetes Metab Rev 1987,3:111-126.
34)Alberti KGMM,Christensen NJ,Iversen J,Orskov H:Role of glucagon and other hormones in development of diabetic ketoacidosis,Lancet,1979;i:1307-1311.
35)Schade Ds,Eaton RP.The temporal relationship between endogenously secreted stress hormone and metabolic decompensation in diabetic man.J Clin Endocrinol Metab,1980;50:131-136.
36)Mc Garry JD,Dobbins RL. Fatty acids, Lipotoxicity and insulin resistance.Diabetologia;1999,42:128-138.
37)McGray JD:Lily lecture 1978 :new perspectives in the regulation of ketogenesis .Diabetes ,1979,28:517-523.
38)Nurjhan N,Consoli A,Gerich J:Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.J clin Invest,1992,89:169-175.
39)McGarry JD,Woeltijie KF,KuwajimaM,Foster DW:Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase.Diabetes Metab Rev ;1989,5:271-284.
40)Balasse EO ,Fery F.Ketone body production and disposal:effects of fasting ,diabetes and exercise.Diabetes Metab Rev,1989,5:247-270.
41)Reichard GA Jr,Skutches CL,Hoeldtke RD,et al.Acetone metabolism in humans during diabetic ketoacidosis.Diabetes;1986,35:668-74.
42)DeFronzo RA, Matzuda M, Barret E. Diabetic Ketoacidosis: A combined metabolic-nephrologic approach to therapy. Diabetes Rev 1994; 2:209-38.
43)Kitabchi AE, Umpierrez GE, Murphy MB. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. In: DeFronzo RA, Ferrannini E, Keen H and Zimmet P, eds). International Textbook of Diabetes Mellitus, 3rd edition. John Wiley & Sons, Ltd. Chichester, UK. 2004;1101-1119.
44)Barnes AJ, Bloom SR, George K, et al. Ketoacidosis in pancreatectomized man. N Engl J Med 1977; 296: 1250.
45)Cahill GF:Starvation in man.N Engl J Med ,1970,282:675-688.
46) Stentz FB, Umpierrez GE, Cuervo R, et al. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes ,2004,53:2079-2086.
47)Yu SS,Kitabchi AE.Biological activity of proinsulin and related peptides in fat tissue.J Biol Chem ,1973,248:3753-61.
48)Schade DS,Eaton RP.Dose response to insulin in man:differential effects on glucose and ketone body regulation.J Clin Endocrinol Metab,1977,44:1038-53.
49)Gerich JE,Martin MM,Recant LL.Clinical and metabolic characteristic of hyperosmolar coma.Diabetes,1971;20:228-38.
50)Marshal SM,Alberti KGGM.Diabetic ketoacidosis.Diabetes Ann,1987,3:498-526.
51)Wachtel TJ, Silliman RA, Lamberton P. Predisposing factors for the diabetic hyperosmolar state. Arch Intern Med 1987; 147:499-501.
52) Newcomer JW: Second generation (atypical) antipsycotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19 Suppl 1:1-93.
53)Polonsky WH, Anderson BJ, Lohrer PA, et al. Insulin omission in women with IDDM. Diabetes Care. 1994;17:1178-1185.
54)Warner GA, Greene GS, Buschsbaum MS, et al. Diabetic ketoacidosis associated with cocaine use. Arch Intern Med.1998; 158: 1799-1802.
55)Nyenwe EA, Loganathan RS, Blum S, et al. Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocrine Practice;2007,13:22-29.
56)Peden NR, Broatan JT, McKenry JB: Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion. Diabetes Care. 1984;7: 1-5.
57)Weissberg-benchell JT,Antisdel-Lomaglio J,Seshadri R:Insulin pump therapy :a meta-analysis.Diabetes Care;2003, 26:1079-1087.
58)Soveid M, Ranjbar-Omrani G. Ketoacidosis as the primary manifestation of acromegaly. Arch Iranian Med. 2005;8:326-328.
59)Katz JR, Edwards R, Kahn M, etal. Acromegaly presenting with diabetic ketoacidosis. Postgrad Med J. 1996; 72: 682-683.
60)Vidal-Cortada J, Conget-Donlo JI, Navarro-Tellex MP, et. al. Diabetic ketoacidosis as the first manifestation of acromegaly. An Med Interna. 1995;12: 76-78.
61)Szeto CC, Li KY, Ko GT, et. al. Acromegaly presenting in a woman with diabetic ketoacidosis and insulin resistance. Int J Clin Pract. 1997;51:476-477.
62)Umpierrez GE, Casals MM, Gebhart SP, et al. Diabetic ketoacidosis in obese African-Americans. Diabetes. 1995; 44:790-795.
63)Umpierrez GE,Smiley D,Kitabchi AE.Narrative review:Ketosis -prone type 2 diabetes.Ann Intern Med, 2006 Mar 7;144(5):350-7.
64)Kitabchi AE. Editorial: Ketosis-prone diabetes-A new subgroup of patients with atypical type 1 and type 2 diabetes? J Clin End Metab ,2003,88:5087-5089.
65)Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes 53. 2004;645-653.
66) Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003;88:5090-5098.
67)Umpierrez GE, Woo W, Hagopian WA, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African Americans with diabetic ketoacidosis. Diabetes Care 1999; 1517-23.
68) Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes. 1994; 43:741-745.
69)Sobngwi E, Gautier JF, Kevorkian JP, et al. High prevalence of glucose 6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposed to ketosis-prone diabetes J Clin End Metab 90. 2005;90(8): 4446-4451.
70)Umpierrez G, Freire AX: Abdominal pain in patients with hyperglycemic crises. J Crit Care 17:63-67, 2002.
71)Campbell IW, Duncan LJ, Innes JA, et al. Abdominal pain in diabetic metabolic decompensation. Clinical significance. JAMA,1975; 233 : 166-168.
72) Umpierrez GE,Friere AX. Abdominal pain in patients with hyperglycemic crises.J Crit Care. 2002 ;17:63-7.
73)Matz`R :Hypothermia in diabetic acidosis. Hormones ;1972,3:36-41.
74)Morris LR,Kitabchi AE.Efficacy of Low-Dose Insulin Therapy for Severly Obtunded Patientsin Diabetic Ketoacidosis.Diabetes Care,1980,3:53-56.
75)Alberti KGMM ,Nattress M.Severe diabetic acidosis .Med Clin North Am,1978,62:799-814.
76)Ruderman NB,Goodman MN.Brain metabolism in diabetes.Horm Metab Res,1980,9:1-8.
77)Rosival V.The influence of blood hydrogen ion concentration on the level ofconsciousness in diabetic ketoacidosis.Ann Clin Res ,1987,19:23-25.
78)Fulop M,Rosenblatt A,Kreitzer SM,Gerstenhaber B.Hyperosmolar nature of diabetic coma.Diabetes,1975,24:594-599.
79)Edge JA,Roy Y,Bergomi A,et al.Conscious level in children with diabetic ketoacidosis is related to severity of acidosis and not to blood glucose concentration.Pediatric Diabetes,2006,7:11-15.
80)Umpierrez GE ,Kelly JP,Navarrete JE,et al.Hyperglycemic crises in urban blacks.Arch Intern Med ,1997,157:669-675.
81) Freirre AX,Umpierrez GE,Bekele Afessa,et al.Predictors of Intensive Care Unit and Hospital Length of Stay in Diabetic Ketoacidosis.J of Critic Care,2002;17:202-211.
82) Arieff AI,Caroll HM.Cerebral edema and depression of sensorium in nonketotic hyperosmolar coma.Diabetes ,1974,24:594-599.
83)Guisado R,Arieff AL:Neurologic manifestations of diabetic comas:correlation with biochemical alterations in brain.Metabolism ,1975;24:665-679.
84)Harden CL,Rosenbaum DH,Daras M:Hyperglycemia presenting with occipital seizures.Epilepsia ,1991,32:215-220.
85)Umpierez GE,Khajavi M,Kitabchi AE :Diabetic ketoacidosis and hyperglycaemic hyperosmolar nonketotic syndrome.Am j Med Sci ,1996,311:225-233.
86)Robin AP,Ing TS,Lancaster GA,et al:Hyperglycemia-induced hyponatremia:A fresh look. Clin Chem,1979,25:496-497.
87)Kaminska ES ,Pourmotabbed G:Spurious laboratory values in diabetic ketoacidosis and hyperlipidemia.Am J Emerg med,1993,11:77-80.
88)Adrogue HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine. 1986,65: 163-171.
89)Abramson E,Arky R:Diabetic acidosis with initial hypokalemia :therapeutic implications.JAMA ,1966,196:401-403.
90)Wilson HK,Keuer SP,Lea AS ,et al:Phosphate therapy in diabetic ketoacidosis.Arch Intern Med 1982,142:517-520.
91)Slovis CM, Mark VG, Slovis RJ, Bain RP: Diabetic ketoacidosis & infection leukocyte count and differential as early predictors of infection. Am J. Emeg. Med. 1978,5: 1-5.
92) Nematollahi LR,Kitabchi AE,Larijani B,Taheri E,et al.Catecholamine induced leukocytosis in acute stress of hypoglycemia(abstract No.95 ).J of Investigative Med, 2007,55:S262.
93) Bewsher PD,Petrie JC,Worth HGI:Serum lipid levels in hyperosmolar non-ketotic diabetic coma.BMJ,1970,3:82-84.
94)Vinicor F, Lehrner LM, Karn RC, et al. Hyperamylasemia in diabetic ketoacidosis: sources and significance. Ann Intern Med. 1979, 91: 200-204.
95)Yadav D, Nair S, Norkus EP. Nonspecific hyperamylasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol. 2000; 95:3123-8.
96)Gerard SK, Rhayam-Bashi H: Characterization of creatinine error in ketotic patients: a prospective comparison of alkaline picrate methods with an enzymatic method. Am J Clin Pathol. 1985; 84: 659-661.
97)Stephens JM,Sulway MJ,Watkins PJ:Relationship of blood acetoacetate and B- hydroxybutyrate in diabetes.Diabetes,1971,20:485-489.
98)Porter WH,Yao HH,Karounos DG.Laboratory and clinical evaluation of assays for beta hydroxybutyrate .Am J clin Pathol,1997,107:353-68.
99)Fulop M,Murthy V,Michilli A,et al.Serum beta-hydroxybutyrate measurement in patients with uncontrolled diabetes mellitus .Arch Intern Med ,1999,159:381-9.
100) Csako G, Elin RJ. Unrecognized false-positive ketones from drugs containing free sulfhydryl groups. JAMA. 1993; 269: 1634.
101)Halperin ML,Hammeke M,Jose RG,Jungas RL:Metabolic acidosis in the alchoholic :a pathophysiologic approach.Metabolism ,1983;32:308-315.
102)Bjellerup P, Kaliner A, Kollind M. GLC Determination of Serum-Ethylene Glycol Interferences in Ketotic Patients. J Toxicol Clin Toxicol 1994; 32:85-7.
103)Paulson WD,Gadallah MF:Diagnosis of mixed acid-base disorders in diabetic ketoacidosis.Am J med Sci,1993,306:295-300.
104)Freidenberg GR, Kosnik EJ, Sotos JF. Hyperglycemic coma after suprasellar surgery. N Engl J Med. 1980; 303:863-9.
105)Hillman K. Fluid Resuscitation in Diabetic Emergencies-A Reappraisal. Intensive Care Med 1987; 13:4-8.
106)Bratusch-Marrain PR, Komajati M, Waldhausal W. The effect of hyperosmolarity on glucose metabolism. Pract Cardiol 1985; 11:153-63.
107)Waldhausl W, Kleinberger G, Korn A, et al. Severe Hyperglycemia: Effects of rehydration on endocrine derangements and blood glucose concentration. Diabetes 1979; 28:577-84.
108)Rosenbloom AL.Intracerebral crises during treatment of diabetic ketoacidosis .Diabetes Care,1990,13:22-33.
109)Maccario M, Messis CP:Cerebral edema complicating treated nonketotic hyperglycemia.Lancet,1969,2:352-353.
110) Fisher JN,Shahshahani MN,Kitabchi AE.Diabetic ketoacidosis: low dose insulin therapy by various routes. N Engl J Med. 1977;297: 238-47.
111) Sacks HS, Shahshahani MN, Kitabchi AE, et al. Similar responsiveness of diabetic ketoacidosis to low-dose insulin by intramuscular injection and albumin-free infusion. Ann Intern Med.1979;90:36-42.
112) Burghen GA,Etteldorf JM,Fisher JN,Kitabchi AE. Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care. 1980 ;3(1):15-20.
113) Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004;117:291-296.
114)Umpierrez GE, Cuervo R, Karabell A, et al. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004;27:1873-1878.
115) Della Manna T, Steinmetz L, Campos PR, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005;28:1856-1861.
116)Atchley DW,Loeb RF,Richards DW ,et al.A detailed study of electrolyte balances following withdrawal and reestablishment of insulin therapy.J Clin Invest ,1933,12:681-95.
117)Beigelman PM. Potassium in severe diabetic ketoacidosis (editorial). Am J Med. 1973; 54:419-420.
118)Abramson E, Arky R. Diabetic acidosis with initial hypokalemia: therapeutic implications. JAMA. 1966, 196:401-403.
119)Kitabchi AE,Murphy MB,When is Bicarbonate Appropriate in Treating Metabolic Acidosis ,including Diabetic Ketoacidosis? In (Gitnick G,Barnes HV,Duffy TP,Lewis RP,Winterbauer RH,eds),Debates in Medicine.Chicago,Year Book Medical Publisher,200-233,1990.
120)Viallon A, Zeni F, Lafond P, et al. Does bicarbonate therapy improve the management of severe diabetic ketoacidosis? Crit Care Med.1999; 27:2690-2693.
121)Krane EJ,Rockoff MA,Wallman JK,Wofsdorf JI:Subclinical brain swelling in children during treatment of diabetic ketoacidosis.N Engl J Med 1985,312:1147-1151.
122)Glaser NS, Wooten-Gorges SL, Marcin JP, et al. Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediar. 2004;145 (2):149-150.
123)Okuda Y, Adrogue HJ, Field JB, et al. Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis in childhood. J Clin Endocrinol Metab. 1996; 81:314.
124) Morris LR, Murphy MB, Kitabchi AE: Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986;105:836-840
125)Lever E,Jaspan JB:Sodium bicarbonate therapy in severe diabetic ketoacidosis .Am J Med 1983,75:263-268.
126)Green SM,Rothrock SG,HO JD,et al:Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis .Ann Emerg Med 1998,31:41-48.
127)Winter RJ, Harris CJ, Phillips LS, et al. Diabetic Ketoacidosis: Induction of Hypocalcemia and Hypomagnesemia by Phosphate Therapy. Am J Med. 1979;67:897-900 .
128)Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 1983; 57:177-80.
129)Keller V, Berger W: Prevention of hypophosphalemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes. 1980;29:87-95
130)Kreisberg RA. Phosphorus Deficiency and Hypophosphatemia. Hosp Pract 1977;12:121-8
131) Adrogue HJ, Wilson H, Boyd AE, et al. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med 1982; 307:1603-10.
132)Kelly AM. The case for venous rather than arterial blood gases in diabetic ketoacidosis. Emerg Med Australas. 2006; 18(1): 64-7.
133)Kitabchi AE, Murphy MB. Consequences of insulin deficiency. (Skyler JS, Ed). In: Atlas of Diabetes. Lippincott, 3 rd edition. Williams and Wilkins, Philadelphia 2005.
134) Fleckman AM. Diabetic ketoacidosis. Endocrinol Metabol Clin North Am. 1993; 22:181-207.
135) Oh MS, Carroll HJ, Goldstein DA, et al. Hyperchloremic acidosis during the recovery phase of diabetic ketosis. Ann Intern Med. 1978;89 (6): 925-927.
136)Duck SC, Wyatt DT: Factors associated with brain herniation in the treatment of diabetic ketoacidosis. J Pediatr. 1988;113:10-14.
137)Silver SM, Clark EC, Schroeder BM, et al. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. Kidney Int. 1997;51:1237-1244.
138)Arieff Al.Cerebral edema complicating nonketotic hyperosmolar coma.Mineral Electrolyte Metab.1986;12:383-389.
139)Smedman L, Escobar R, Hesser, et al. sub-clinical cerebral edema does not occur regularly during treatment for diabetic ketoacidosis. Acta Paediatr 1997; 86: 1172.
140)Isales CM, Min L, Hoffman WH. Acetoacetateand betahydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. J Diabet Complications. 1993; 13:9
141)Edge JA. Cerebral oedema during treatment of diabetic ketoacidosis. Are we any nearer finding a cause? Diabetes Metab Res Rev 2000; 16: 316.
142)Carroll P,Matz R:Adult Respiratory distress syndrome complicating severly uncontrolled diabetes mellitus :Report of nine cases and a review of thelitrature.Diabetes care,1982,5:574-580.
143)Buyukasik Y, Illeri NS, Haznedarogu IC, et al Enhanced subclinical coagulation activation during diabetic ketoacidosis. Diabetes Care.1998; 21:868-875.
144)Trimperley WR,preston FE,Ward JD:Cerebral intravascular coagulation in diabetic ketoacidosis.lancet,1974,1:952-956.
145)Mclaren EH,Cullen DR,Brown MJ :Coagulation abnormalities in diabetic coma before and 24 hours after treatment.Diabetologica ,1979,17:345-349.
146)Foster DW :Diabetic ketoacidosis In Krieger DT ,Brandin CW (eds ):Current Therapy in Endocrinology and Metabolism,Toronto .BC Decker ,1985,p.268-270.
147)Musey VC, Lee JK, Crawford R, et al. Diabetes in urban African-Americans. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care. 1995;18:483-489.
148)Maldonado MR, Chong ER, Oehl MA, et al. Economic Impact of Diabetic Ketoacidosis in a Multiethnic Indigent Population: Analysis of costs based on the precipitating cause. Diabetes Care. 2003;26:1265-1269.
149)Laffel LM, Brackett J, Ho J, et al. Changing The Process of Diabetes Care Improves Metabolic Outcomes and Reduces Hospitalizations. Qual Manag Health Care 1998; 6:53-62.
150)Rewers A, Chase HP, Mackenzie T, et al. Predictors of Acute Complications in Children with Type 1 Diabetes. JAMA 2002; 287:2511-18.
151)Vanelli M,Chiari G,Ghizzoni L,Costi G,Giacalone T,Chiarelli F :Effectiveness of a prevention program for diabetes ketoacidosis in children : an 8-year study in schools and private practices.Diabetes care 1999;22:7-9.
152)Runyan JW JR,Zwaag RV,Joyner MB,Miller ST.The Memphis diabetes continuing care program.Diabetes Care.1980,3:382-6.